ArticleFrontiers in oncology2026
Pancreatic hamartoma presenting with sleep-related behavioral abnormalities due to neuroglycopenia: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic hamartoma (PH) is an exceedingly rare benign non-neoplastic lesion of the pancreas. Owing to its nonspecific clinical and radiological features, it is prone to misdiagnosis. Among its various subtypes, functionally active pancreatic hamartomas with distinct endocrine activity have only been sporadically reported in the literature as individual cases. We report the case of a 58-year-old female patient whose initial presentation was characterized by paroxysmal behavioral abnormalities during nocturnal sleep, manifesting as sudden agitation, arm-flinging, and purposeless stereotyped movements after sleep onset. During these episodes, the patient exhibited a confusional state with subsequent complete amnesia for the events, a clinical phenotype highly suggestive of REM sleep behavior disorder (RBD) or frontal lobe epilepsy. In-hospital monitoring revealed refractory nocturnal hypoglycemia. Imaging studies identified a mass in the pancreatic tail, and the patient underwent laparoscopic distal pancreatectomy. Postoperative histopathological and immunohistochemical examination confirmed the diagnosis of pancreatic hamartoma, composed predominantly of islet cells (approximately 90%) with associated islet cell tumor-like hyperplasia. Following surgery, the patient's nocturnal hypoglycemia and sleep-related behavioral abnormalities resolved completely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.